Clinical characteristics of SMN patient cohort
| Characteristic . | n . |
|---|---|
| Total patients | 19 |
| Primary cancer | |
| Median age at diagnosis, y (range) | 4 (0-14) |
| ALL | 14 |
| AML/MDS | 1 |
| Lymphoma | 4 |
| SMN | |
| Median age at diagnosis, y (range) | 13.5 (5-44) |
| Median interval from primary cancer, y (range) | 6.5 (2-30) |
| Hematologic malignancies | 14 |
| ALL | 1 |
| AML/MDS | 12 |
| Lymphoma | 1 |
| Solid tumor | 5 |
| CNS tumor | 1 |
| Non-CNS tumor | 4 |
| Characteristic . | n . |
|---|---|
| Total patients | 19 |
| Primary cancer | |
| Median age at diagnosis, y (range) | 4 (0-14) |
| ALL | 14 |
| AML/MDS | 1 |
| Lymphoma | 4 |
| SMN | |
| Median age at diagnosis, y (range) | 13.5 (5-44) |
| Median interval from primary cancer, y (range) | 6.5 (2-30) |
| Hematologic malignancies | 14 |
| ALL | 1 |
| AML/MDS | 12 |
| Lymphoma | 1 |
| Solid tumor | 5 |
| CNS tumor | 1 |
| Non-CNS tumor | 4 |
CNS, central nervous system; MDS, myelodysplastic syndrome.